Effect of Spontaneous Breathing in APRV Mode on Respiratory Physiology of ARDS Patients
NCT: NCT07798154 · NOT_YET_RECRUITING
Brief Summary
This is a single-center, prospective, randomized, three-period crossover physiological study in adult patients with moderate-to-severe acute respiratory distress syndrome (ARDS, PaO₂/FiO₂ ≤150 mmHg). Each enrolled subject will receive all three APRV ventilation conditions in random sequence: low-level spontaneous breathing (spontaneous minute-ventilation proportion 10%-30%), high-level spontaneous breathing (31%-50%), and fully suppressed spontaneous breathing as control. A 30-minute wash-out period is set between each condition to restore unified physiological baseline. Primary outcome is ventilation-perfusion mismatch percentage (mismatch%) measured by Electrical Impedance Tomography (EIT). Secondary outcomes include EIT-derived pulmonary parameters, respiratory mechanics, hemodynamics, diaphragmatic function and safety profiles. Only short-term, reversible ventilator and sedation adjustments will be performed; routine clinical management remains unchanged throughout the trial.
Frequently Asked Questions
What is Effect of Spontaneous Breathing in APRV Mode on Respiratory Physiology of ARDS Patients?
Effect of Spontaneous Breathing in APRV Mode on Respiratory Physiology of ARDS Patients is a clinical trial registered under NCT07798154. Current status: NOT_YET_RECRUITING.
What is the status of NCT07798154?
The current status of NCT07798154 (Effect of Spontaneous Breathing in APRV Mode on Respiratory Physiology of ARDS Patients) is: NOT_YET_RECRUITING.
When did Effect of Spontaneous Breathing in APRV Mode on Respiratory Physiology of ARDS Patients start?
Effect of Spontaneous Breathing in APRV Mode on Respiratory Physiology of ARDS Patients started on 2026-10-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.